Public Company News

RYB Education, Inc. Announces Divesture of Directly Operated Kindergarten Business and Proposes the Change of Name

BEIJING, March 3, 2022 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB) announces that its subsidiaries have entered into termination agreements with certain variable interest entities, a decision made after careful consideration of the regulatory landscape and the Company...

2022-03-03 17:30 4074

RYB Education, Inc. to Hold an Extraordinary General Meeting on May 13, 2022

BEIJING, March 3, 2022 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB), a leading early childhood education service provider in China, today announced that it will hold an Extraordinary General Meeting of Shareholders (the "EGM") at 4/F, No. 28 Building, Fangguyuan Section...

2022-03-03 17:30 4080

TD Holdings, Inc. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

SHENZHEN, China, March 2, 2022 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider inChina, today announced that onMarch 1, 2022, the Company received a written notification from the Nasdaq's Listing Qualifications Department granting another 18...

2022-03-03 05:30 3844

Farmmi Announces Closing of US$6.0 Million Private Placement

LISHUI, China, March 2, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier inChina, today announced that it closed a private placement transaction (the "Private Placement"), raising approximatelyUS$6.0 million in gross proceeds, from the...

2022-03-03 05:30 4096

ReneSola Power to Participate at the 34th Annual Roth Conference

STAMFORD, Conn., March 2, 2022 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, today announced that the management team will participate at the 34th Annual Rot...

2022-03-03 05:05 2584

Akeso Announces Clinical Trial Collaboration with Chipscreen Biosciences to Evaluate Cadonilimab in Combination with Chiauranib for Extensive-Stage Small-Cell Lung Cancer

HONG KONG, March 2, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso"), a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of innovative antibody drugs that are affordable to patients worldwidetoday announced that it has entered into a collab...

2022-03-03 01:34 2903

Skillful Craftsman Announces Strategic Alliance to Develop Smart Technical Skills Training Metaverse Platform

WUXI, China, March 2, 2022 /PRNewswire/ -- Skillful Craftsman Education Technology Ltd. ("the Company") (NASDAQ: EDTK), an education technology company providing interactive online learning services, announced that the Company entered into a strategic cooperation agreement (the "Agreement") with ...

2022-03-02 21:30 4212

Tantech Holdings Receives NASDAQ Minimum Bid Price Requirement Extension

LISHUI, China, March 2, 2022 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), announced today that onMarch 1, 2022, it received notification from The Nasdaq Stock Market LLC ("NASDAQ") confirming the Company has been granted an additional 180 calendar day period f...

2022-03-02 21:00 3839

Missfresh Expands China-wide Direct-Supply Vegetable Farm Network to Total More Than 1,300 Hectares

BEIJING, March 2, 2022 /PRNewswire/ -- Missfresh Limited  ("Missfresh" or the "Company") (NASDAQ: MF), a pioneer inChina's neighborhood retail industry, has just signed an agreement to add nearly 70 hectares of land in Luliang County inYunnan Province to its China -wide ...

2022-03-02 20:30 5501

Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business

SEOUL, South Korea, March 2, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment ofRichard S. Creager, Ph.D., as the CEO of itsUnited States subsidiary, Seegene Technologies

2022-03-02 20:00 2255

InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China

BEIJING, March 1, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today the Investigational New Drug (IND) approval of its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib by China National Medical Products Administration (NMPA) to start ph...

2022-03-02 10:37 3000

WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year

SHANGHAI, March 1, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, today announced that the company has won the 2022 CMO Leadership Awards in all six core categories (i.e., capabilities, compatibility, expertise, reliability, quality and service).2022 m...

2022-03-02 10:07 2801

Tundra Technical Solutions Joins Forces with LiveHire to Deliver Innovative Contingent Direct Sourcing Solutions plus Advance Women in STEM Careers

MIAMI, March 1, 2022 /PRNewswire/ -- LiveHire (LVH:ASX), a global award-winning direct sourcing and total talent technology provider, has formed a strategic partnership with Tundra Technical Solutions, a global staffing leader hiring diverse talent for the world's most recognizable brands, to del...

2022-03-02 05:22 2393

JS Global's SharkNinja Team to Participate in the Bank of America 2022 Consumer & Retail Technology Conference

NEEDHAM, Mass., March 1, 2022 /PRNewswire/ -- JS Global Lifestyle Company Limited (Hong Kong: 1691) ("JS Global"), a world-leading producer of small household appliances, today announced that the management team of its SharkNinja brand, an innovation leader in the consumer floorcare and robotic ...

2022-03-02 01:01 2432

Sunyard Carved Out A Successful 2021 And Embraces 2022

HANGZHOU, China, March 1, 2022 /PRNewswire/ -- Sunyard Technology, the leading global payment solution provider, wrapped up its full-year 2021 results and reported 2022 determination at a recent meeting, demonstrating the sheer commitment and action to improve, innovate and develop. Last year sa...

2022-03-01 23:00 2555

Smart brand Aohi Unveils A New Generation of High Power Fast Charger: Magcube 100W

SHENZHEN, China, March 1, 2022 /PRNewswire/ -- Aohi, a new smart brand with great competitiveness and ambition in the mobile charging and consumer electronics industry, unveiled the third blockbuster new fast charger in the magcube series-Magcube 100W fast charger, which is designed to quickly an...

2022-03-01 21:40 2801

Recon Announces some recent contracts and business progress

BEIJING, March 1, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced several contracts signed recently by its domestic VIE companies and reported the progress on its business segments so far for the year 2022: * For its automation business segm...

2022-03-01 21:30 3970

Color Star Technology Co., Ltd. (NASDAQ: CSCW) Announces Partnership France's Galtiscopio Gatti to Enter into 'Color World' Metaverse Platform

NEW YORK, March 1, 2022 /PRNewswire/ -- Color Star Technology Co., Ltd. (NASDAQ: CSCW) (hereinafter referred to as "Color Star" or the "Company"), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence ("AI") in the ent...

2022-03-01 21:30 4158

51job, Inc. Enters into an Amended Merger Agreement for Going-Private Transaction

SHANGHAI, March 1, 2022 /PRNewswire/ -- 51job, Inc. (Nasdaq: JOBS) ("51job" or the "Company"), a leading provider of integrated human resource services inChina , announced today that it has entered into an amendment to its previously announced Agreement and Plan of Merger dated as ofJune 21, 2021 ...

2022-03-01 21:30 4985

Kintor Pharma Announces First Patient Dosing in Phase II Clinical Trial of KX-826 for Treatment of Androgenic Alopecia Patients in the US

SUZHOU, China, March 1, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the first patient dosing in its phase II clinical trial of KX-826 ("...

2022-03-01 20:30 2641
1 ... 683684685686687688689 ... 750